Selected research
Industry Research
Medical Fibrin Sealant Industry Research Report 2026
Market perspective
The global Medical Fibrin Sealant market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Medical Fibrin Sealant is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Medical Fibrin Sealant is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Medical Fibrin Sealant is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Medical Fibrin Sealant include Johnson & Johnson, Baxter, CSL Behring, Hualan Biological Engineering, Zhejiang Xilinte Pharmaceutical, Harbin Hanbang Medical, Haohai Biological Technology, Shanghai Songli Bio and Shanghai RAAS Blood Products, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Medical Fibrin Sealant market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medical Fibrin Sealant Market by Company
Johnson & Johnson
Baxter
CSL Behring
Hualan Biological Engineering
Zhejiang Xilinte Pharmaceutical
Harbin Hanbang Medical
Haohai Biological Technology
Shanghai Songli Bio
Shanghai RAAS Blood Products
Medical Fibrin Sealant Segment by Type
Pig Source
Human Source
Medical Fibrin Sealant Segment by Application
Clinical
Research
Medical Fibrin Sealant Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Fibrin Sealant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Fibrin Sealant and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Fibrin Sealant.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Medical Fibrin Sealant manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Medical Fibrin Sealant by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Medical Fibrin Sealant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pig Source
- Human Source
Applications
- Clinical
- Research
Companies covered
- Johnson & Johnson
- Baxter
- CSL Behring
- Hualan Biological Engineering
- Zhejiang Xilinte Pharmaceutical
- Harbin Hanbang Medical
- Haohai Biological Technology
- Shanghai Songli Bio
- Shanghai RAAS Blood Products
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Medical Fibrin Sealant Market Size (2021-2032)
- 2.2.2 Global Medical Fibrin Sealant Sales (2021-2032)
- 2.2.3 Global Medical Fibrin Sealant Market Average Price (2021-2032)
- 2.3 Medical Fibrin Sealant by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pig Source
- 2.3.3 Human Source
- 2.4 Medical Fibrin Sealant by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinical
- 2.4.3 Research
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Medical Fibrin Sealant Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Medical Fibrin Sealant Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Medical Fibrin Sealant Revenue of Manufacturers (2021-2026)
- 3.4 Global Medical Fibrin Sealant Average Price by Manufacturers (2021-2026)
- 3.5 Global Medical Fibrin Sealant Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Medical Fibrin Sealant, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Medical Fibrin Sealant, Product Type & Application
- 3.8 Global Manufacturers of Medical Fibrin Sealant, Established Date
- 3.9 Global Medical Fibrin Sealant Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Johnson & Johnson
- 4.1.1 Johnson & Johnson Company Information
- 4.1.2 Johnson & Johnson Business Overview
- 4.1.3 Johnson & Johnson Medical Fibrin Sealant Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Johnson & Johnson Medical Fibrin Sealant Product Portfolio
- 4.1.5 Johnson & Johnson Recent Developments
- 4.2 Baxter
- 4.2.1 Baxter Company Information
- 4.2.2 Baxter Business Overview
- 4.2.3 Baxter Medical Fibrin Sealant Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Baxter Medical Fibrin Sealant Product Portfolio
- 4.2.5 Baxter Recent Developments
- 4.3 CSL Behring
- 4.3.1 CSL Behring Company Information
- 4.3.2 CSL Behring Business Overview
- 4.3.3 CSL Behring Medical Fibrin Sealant Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 CSL Behring Medical Fibrin Sealant Product Portfolio
- 4.3.5 CSL Behring Recent Developments
- 4.4 Hualan Biological Engineering
- 4.4.1 Hualan Biological Engineering Company Information
- 4.4.2 Hualan Biological Engineering Business Overview
- 4.4.3 Hualan Biological Engineering Medical Fibrin Sealant Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hualan Biological Engineering Medical Fibrin Sealant Product Portfolio
- 4.4.5 Hualan Biological Engineering Recent Developments
- 4.5 Zhejiang Xilinte Pharmaceutical
- 4.5.1 Zhejiang Xilinte Pharmaceutical Company Information
- 4.5.2 Zhejiang Xilinte Pharmaceutical Business Overview
- 4.5.3 Zhejiang Xilinte Pharmaceutical Medical Fibrin Sealant Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Zhejiang Xilinte Pharmaceutical Medical Fibrin Sealant Product Portfolio
- 4.5.5 Zhejiang Xilinte Pharmaceutical Recent Developments
- 4.6 Harbin Hanbang Medical
- 4.6.1 Harbin Hanbang Medical Company Information
- 4.6.2 Harbin Hanbang Medical Business Overview
- 4.6.3 Harbin Hanbang Medical Medical Fibrin Sealant Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Harbin Hanbang Medical Medical Fibrin Sealant Product Portfolio
- 4.6.5 Harbin Hanbang Medical Recent Developments
- 4.7 Haohai Biological Technology
- 4.7.1 Haohai Biological Technology Company Information
- 4.7.2 Haohai Biological Technology Business Overview
- 4.7.3 Haohai Biological Technology Medical Fibrin Sealant Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Haohai Biological Technology Medical Fibrin Sealant Product Portfolio
- 4.7.5 Haohai Biological Technology Recent Developments
- 4.8 Shanghai Songli Bio
- 4.8.1 Shanghai Songli Bio Company Information
- 4.8.2 Shanghai Songli Bio Business Overview
- 4.8.3 Shanghai Songli Bio Medical Fibrin Sealant Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Shanghai Songli Bio Medical Fibrin Sealant Product Portfolio
- 4.8.5 Shanghai Songli Bio Recent Developments
- 4.9 Shanghai RAAS Blood Products
- 4.9.1 Shanghai RAAS Blood Products Company Information
- 4.9.2 Shanghai RAAS Blood Products Business Overview
- 4.9.3 Shanghai RAAS Blood Products Medical Fibrin Sealant Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Shanghai RAAS Blood Products Medical Fibrin Sealant Product Portfolio
- 4.9.5 Shanghai RAAS Blood Products Recent Developments
5 Global Medical Fibrin Sealant Market Scenario by Region
- 5.1 Global Medical Fibrin Sealant Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Medical Fibrin Sealant Sales by Region: 2021-2032
- 5.2.1 Global Medical Fibrin Sealant Sales by Region: 2021-2026
- 5.2.2 Global Medical Fibrin Sealant Sales by Region: 2027-2032
- 5.3 Global Medical Fibrin Sealant Revenue by Region: 2021-2032
- 5.3.1 Global Medical Fibrin Sealant Revenue by Region: 2021-2026
- 5.3.2 Global Medical Fibrin Sealant Revenue by Region: 2027-2032
- 5.4 North America Medical Fibrin Sealant Market Facts & Figures by Country
- 5.4.1 North America Medical Fibrin Sealant Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Medical Fibrin Sealant Sales by Country (2021-2032)
- 5.4.3 North America Medical Fibrin Sealant Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Medical Fibrin Sealant Market Facts & Figures by Country
- 5.5.1 Europe Medical Fibrin Sealant Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Medical Fibrin Sealant Sales by Country (2021-2032)
- 5.5.3 Europe Medical Fibrin Sealant Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Medical Fibrin Sealant Market Facts & Figures by Country
- 5.6.1 Asia Pacific Medical Fibrin Sealant Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Medical Fibrin Sealant Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Medical Fibrin Sealant Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Medical Fibrin Sealant Market Facts & Figures by Country
- 5.7.1 South America Medical Fibrin Sealant Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Medical Fibrin Sealant Sales by Country (2021-2032)
- 5.7.3 South America Medical Fibrin Sealant Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Medical Fibrin Sealant Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Medical Fibrin Sealant Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Medical Fibrin Sealant Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Medical Fibrin Sealant Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Medical Fibrin Sealant Sales by Type (2021-2032)
- 6.1.1 Global Medical Fibrin Sealant Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Medical Fibrin Sealant Sales Market Share by Type (2021-2032)
- 6.2 Global Medical Fibrin Sealant Revenue by Type (2021-2032)
- 6.2.1 Global Medical Fibrin Sealant Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Medical Fibrin Sealant Revenue Market Share by Type (2021-2032)
- 6.3 Global Medical Fibrin Sealant Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Medical Fibrin Sealant Sales by Application (2021-2032)
- 7.1.1 Global Medical Fibrin Sealant Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Medical Fibrin Sealant Sales Market Share by Application (2021-2032)
- 7.2 Global Medical Fibrin Sealant Revenue by Application (2021-2032)
- 7.2.1 Global Medical Fibrin Sealant Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Medical Fibrin Sealant Revenue Market Share by Application (2021-2032)
- 7.3 Global Medical Fibrin Sealant Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Medical Fibrin Sealant Value Chain Analysis
- 8.1.1 Medical Fibrin Sealant Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Medical Fibrin Sealant Production Mode & Process
- 8.2 Medical Fibrin Sealant Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Medical Fibrin Sealant Distributors
- 8.2.3 Medical Fibrin Sealant Customers
9 Global Medical Fibrin Sealant Analyzing Market Dynamics
- 9.1 Medical Fibrin Sealant Industry Trends
- 9.2 Medical Fibrin Sealant Industry Drivers
- 9.3 Medical Fibrin Sealant Industry Opportunities and Challenges
- 9.4 Medical Fibrin Sealant Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst